ASH presentations in San Diego
25 Nov 2016
EORTC will be presenting four posters at the American Society of Hematology’s 58th Annual Meeting and Exposition (December 3-6, 2016) in San Diego
Prophylactic CNS Therapy (with or without Radiation Therapy) in Medium-High Risk Acute Lymphoblastic Leukemia (ALL) Children: Long-Term Outcome Evaluation of the Randomized BFM-oriented Trial 58832 (period 1983-1989) of the EORTC Children Leukemia (Abstract: 2775)
Session 612: Acute Lymphoblastic Leukemia: Clinical Studies: Poster II; Sunday 04.12.2016 – 6:00 PM – 8:00 PM
Location: San Diego Convention Center, Hall GH
Authors: Caroline Piette, Stefan Suciu, Yves Bertrand, Anne Uyttebroeck, Els Vandecruys, Geneviève Plat, Patrick Lutz, Claire Pluchart, Nicolas Sirvent, Maryline Poirée, Pauline Simon, Alina Ferster, Claire Hoyoux, Francoise Mazingue, Robert Paulus, Dominique Plantaz, Caroline Thomas, Caroline Gilotay, Jutte Van Der Werff Ten Bosch, Pierre Simon Rohrlich, Yves Benoit
Impact of Induction Regimen and of Allogeneic Hematopoietic Cell Transplantation on the Outcome in Younger Adults Patients with Acute Myeloid Leukemia with a Monosomal Karyotype: Results from the EORTC/Gimema AML-10 and AML-12 Trials (Abstract: 2847)
Session 617: Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster II; Sunday 04.12.2016 – 6:00 PM – 8:00 PM
Location: San Diego Convention Center, Hall GH
Authors: Frédéric Baron*, Marian Stevens-Kroef*, Giovanna Meloni, Petra Muus, Jean-Pierre Marie, Constantijn J.M. Halkes, Xavier Thomas, Radovan Vrhovac, Giorgina Specchia, François Lefrère Sr, Simona Sica, Marco Mancini, Adriano Venditti, Anne Hagemeijer, Joop Jansen, Sergio Amadori, Theo de Witte, Roel Willemze, Stefan Suciu
* Co first authors
Post-Remission Treatment with Autologous or Allogeneic Bone Marrow Transplantation or Intensive Chemotherapy in Younger AML Patients: Long-Term Follow-up Results of the EORTC/Gimema AML-8A Study (Abstract: 2288)
Session 732: Clinical Allogeneic Transplantation: Results: Poster I; Saturday 03.12.2016 – 5:30 PM – 7:30 PM
Location: San Diego Convention Center, Hall GH
Authors: F. Baron, F. Efficace, L. Cannella, F. Mandelli, R.Willemze, P.Muus, J-P. Marie, D. Ferrero, M. Dictus, P. Fazi, E. La Sala, J-H. Bourhis, F. Fabbiano, A. Bosi, M. Sborgia, G., Martinelli, D. Bron, M. C. Petti, C. J.M. Halkes, W. J.F.M. van der Velden, M. Boccadoro, S. Amadori, R. A. Zittoun and S. Suciu
Impact of Age and Treatment Group in Childhood High Hyperdiploid Low Risk B-Cell Acute Lymphoblastic Leukemia (ALL): Results of the CLG-EORTC 58951 Study (Abstract 1743)
Session 618: Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster I; Saturday 03.12.2016 — 5:30 PM – 7:30 PM
Location: San Diego Convention Center, Hall GH
Authors: Laura Clement, Stefan Suciu, Isabelle Luquet, Alina Ferster, Karima Yakouben, Anne Uytterbroeck, Catherine Paillard, Nicolas Sirvent, Vitor Costa, Barbara De Moerloose, Francoise Mazingue, Emmanuel Plouvier, Martine Munzer, Maryline Poirée, Odile Minckes, Frédéric Millot, Dominique Plantaz, Caroline Piette, Frank Speleman, Hélène Cavé, Jutte VanderWerff-tenBossch, Pierre Simon Rohrlich, Yves Bertrand, Yves Benoit, Geneviève Plat
Related News
EORTC and Immunocore announce enrolment of first patient onto the only active Phase 3 adjuvant trial in uveal melanoma
11 Dec 2024
Minister F. Vandenbroucke visits EORTC Headquarters to strengthen collaborative efforts in clinical cancer research
21 Nov 2024
IMMUcan has completed patient enrolment
12 Nov 2024
EORTC SPRINT clinical cancer study receives support from Rising Tide Foundation to reduce the burden for patients
5 Nov 2024
Pink October at EORTC: Over 60 years of impactful breast cancer research
29 Oct 2024
Spotlight on ENA 2024 News
25 Oct 2024
Do regulations and policies undermine the social value of independent academic research?
25 Oct 2024
EORTC Quality of Life Group’s participation to ISOQOL 2024
10 Oct 2024
New Insights into Glioblastoma Treatment for Older Adults Patients
8 Oct 2024
TOPGEAR trial results show no significant benefit of preoperative chemoradiotherapy on long term survival
24 Sep 2024